

Merck Information
Contact top employees from
Merck
Summary
Merck is a public company that has been in the industry for 134 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals, Biotechnology areas. The position of the CEO is occupied by Robert M. Davis. Its headquarters is located at Kenilworth, New Jersey, USA. The number of employees ranges from 50K to 100K. The annual revenue of Merck varies between 10B and 50B. To connect with Merck employee register on SignalHire.
Industries
Pharmaceuticals
Headquarters Location
Employees Size
10000+ employees
Specialties
Pharmaceutical
SIC Code
2834
DMA Code
New York Metropolitan Area
Founded
1891
Estimated Annual Revenue
$10B - 50B
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2013 | Public Company | 10K - 50K | 53.7B | $6B | |
1976 | Privately Held | 10K - 50K | 18.3B | $2B | |
1848 | Public Company | 50K - 100K | 55.5B | $0 | |
1996 | Public Company | 100K - 9.9M | 50.4B | $0 | |
1830 | Public Company | 50K - 100K | 45.5B | $0 | |
1886 | Public Company | 100K - 9.9M | 89.2B | $0 | |
1994 | Public Company | 50K - 100K | 45.6B | $0 | |
1999 | Public Company | 50K - 100K | 29.5B | $0 | |
1858 | Public Company | 10K - 50K | 44.4B | $0 | |
1876 | Public Company | 10K - 50K | 26.7B | $0 | |
2002 | Privately Held | 50K - 100K | 51.1B | $0 | |
1978 | Public Company | 5.0K - 10K | 11.7B | $0 | |
1980 | - | 10000+ | - | $- | |
1896 | - | 10000+ | - | $- | |
1987 | - | 10000+ | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
Ex-employees switched to
Length of Employment
Employee tenure at Merck shows a diverse range of experience levels:
1% have been with the company for less than 1 year8% for 1–2 years12% for 3–4 years13% for 5–7 years10% for 8–10 years56% have over 11 years of service at MerckEx-employees positions
In Company
In New Company
Contact top employees from
Merck
Art Yanchitis
Director Project Delivery
Taylor Lichtenhahn
Associate Director, US Oncology Marketing (KEYTRUDA Endometrial Cancer)
Ruthie Birger
Associate Principal Scientist
Jodie Rozsa
Associate Director, Benefits
Kathryn Tsemberlis
Paralegal II, /Senior Specialist, Legal Support-Corporate Transactions
Timothy Hajj
Associate Director - Regulatory Affairs (US Subsidiary)
Phillip Kisembo
Associate Director, Regulated Robotics & Data
Dawne Davis
Associate Director, Clinical Operations-Oncology
Linda Bickell
US Oncology Marketing, Customer Engagement and Field Execution Lead
Todd Gruber
Associate Vice President
Marya Chaney
Exec Clinical Director/Distinguished Scientist
Christina Reitmann
Director
Kyle Lurski
Associate Director, Treasury
Kalgi Pandya
Senior Scientist, CMC Regulatory Affairs
Jessica Jewusiak
Senior Clinical Scientist, Oncology
Jason Schafer
Global Scientific Training Director - HIV
Richard Edwards
LIMS analyst
Amanda Fein
Sr. Director, Global Regulatory Lead
Becky Rivera
Associate Director, Global Mobility
Todd Maisano
Associate Principal Scientist - Process R&D
Mary Yagodich
Senior Scientist, Pharmacokinetics, PDMB TSO Regulated Vaccines Outsourcing at Merck
Alexander OBrien
Associate Director - Vaccines CMC
James Varughese
Associate Director, Engineering
Jessica Taskin
Associate Director, US Strategy & Planning
Tarak Patel
Principal Scientist, Statistical Programming
Anne Ollis
Associate Director